Vasovist® (gadofosveset Trisodium) - First Imaging Agent Approved For Magnetic Resonance Angiography (MRA) In The U.S.

EPIX Pharmaceuticals, Inc. (NASDAQ:EPIX), a biopharmaceutical company focused on discovering and developing novel therapeutics through the use of its proprietary and highly efficient in silico drug discovery platform, today announced that the U.S.

More: continued here

Filed under: Cardiovascular on January 3rd, 2009